Guidance Document: Regulatory requirements for Drug Identification Numbers (DINs) - Summary (English, HTML)

View metadata and access the original English HTML file: Guidance Document: Regulatory requirements for Drug Identification Numbers (DINs) - Summary.

Format

HTML

Access

file-only

Publisher-reported update

2021-07-06

When Health Canada authorizes a drug to be marketed in Canada, a Drug Identification Number (DIN) is issued to the manufacturer and printed on the package labels. A DIN indicates that the evaluation of the drug determined that it met the relevant requirements of the Food and Drugs Act and its regulations and the drug has a favourable risk/benefit profile. Manufacturers of prescription and non-prescription drugs must obtain a DIN before they are marketed in Canada

Access original file